RT Journal Article
SR Electronic
T1 Antibody targeting tumor-derived soluble NKG2D ligand sMIC provides dual co-stimulation of CD8 T cells and enables sMIC<sup>+</sup> tumors respond to PD1/PD-L1 blockade therapy
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP 223
DO 10.1186/s40425-019-0693-y
VO 7
IS 1
A1 Zhang, Jinyu
A1 Larrocha, Pablo Saenz-lopez
A1 Zhang, Bin
A1 Wainwright, Derek
A1 Dhar, Payal
A1 Wu, Jennifer D.
YR 2019
UL http://jitc.bmj.com/content/7/1/223.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.